Does the company meet or exceed its previously provided guidance for Q2 2025?

Fundamental view: The press release “Sonendo, Inc. Reports Second‑Quarter 2025 Financial Results and Re‑affirms Financial Guidance” tells us that the company met its previously issued Q2 2025 targets. The phrasing “reaffirms” is used by companies when they have delivered results in line with—or slightly above—what they previously projected, and they have no need to revise the outlook upward or downward. No language in the release indicates an earnings beat or a “beat-and‑raise” situation, so the prudent interpretation is that Sonendo achieved its guidance rather than exceeding it.

Trading implications: Because the results are essentially on‑target, the market is unlikely to see a sharp directional move from the earnings release alone. The stock will probably trade sideways or modestly up on the relief that guidance remains intact, especially if the broader dental‑technology sector is neutral or bullish. Traders could look for a short‑term bounce if the price has already priced in a beat‑and‑raise scenario; otherwise, a cautious “buy the dip” approach may be justified if the stock has under‑performed relative to peers. Watch the next 30‑day moving average for confirmation of a breakout pattern; if it stays above the 20‑day EMA and volume holds, a modest long position could be justified, while a breach below the 20‑day EMA with rising volume would signal a potential downside re‑test.